These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6434546)

  • 1. Growth-inhibitory activity of lymphoid cell plasma membranes. I. Inhibition of lymphocyte and lymphoid tumor cell growth.
    Stallcup KC; Dawson A; Mescher MF
    J Cell Biol; 1984 Oct; 99(4 Pt 1):1221-6. PubMed ID: 6434546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-inhibitory activity of lymphoid cell plasma membranes. II. Partial characterization of the inhibitor.
    Stallcup KC; Burakoff SJ; Mescher MF
    J Cell Biol; 1984 Oct; 99(4 Pt 1):1227-34. PubMed ID: 6332814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lymphoid cell growth by a lipid-like component of macrophage hybridoma cells.
    Stallcup KC; Liu YN; Dorf ME; Mescher MF
    J Immunol; 1986 Apr; 136(8):2723-8. PubMed ID: 3958487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage inhibition of lymphocyte and tumor cell growth is mediated by 25-hydroxycholesterol in the cell membrane.
    Kato H; Horino A; Taneichi M; Fukuchi N; Eto Y; Ushijima H; Komuro K; Uchida T
    Int Arch Allergy Immunol; 1998 Sep; 117(1):78-84. PubMed ID: 9751851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lymphocyte growth by Ulex seed extracts (USE).
    Pirofsky B; Beaulieu R; Davies GH
    Immunology; 1981 Aug; 43(4):653-61. PubMed ID: 7275170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-free medium for murine and human lymphoid and hybridoma cell lines.
    Togami M; Yasuda K; Kariya M
    Cytotechnology; 1991 May; 6(1):33-8. PubMed ID: 1367398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro establishment and some properties of AKR thymoma cell lines.
    Riesenfeld I; Tufveson G; Alm GV
    Acta Pathol Microbiol Scand A; 1977 Sep; 85(5):739-44. PubMed ID: 303433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal murine endogenous lymphoid factor(s) inhibiting lymphocyte functions. I. In vivo effect on allogeneic tumor growth.
    Fejes M; Pasqualini CD; Braun M
    Oncology; 1980; 37(2):96-100. PubMed ID: 6444707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid isolation and lipid characterization of plasma membranes from normal and malignant lymphoid cells of mouse.
    Koizumi K; Shimizu S; Koizumi KT; Nishida K; Sato C; Ota K; Yamanaka N
    Biochim Biophys Acta; 1981 Dec; 649(2):393-403. PubMed ID: 7317406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell hybrids. II. BH2 line-derivation by fusion between two (BW5147 X EL-4R) thymoma lines.
    Bubeník J; Perlmann P; Jónsdóttir I; Kypĕnová H; Bubeníková D; Indrová M; Loudová M
    Neoplasma; 1982; 29(1):3-7. PubMed ID: 6978467
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of lymphoma grafts on natural killer cell activity in AKR and C57BL/6 mice.
    Vaillier D; Labat V; Legrand E; Duplan JF
    Nat Immun Cell Growth Regul; 1986; 5(1):41-9. PubMed ID: 3084955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro stimulation of mouse lymphoid cells by C1300 neuroblastoma cells or tumor membrane extracts.
    Revoltella R; Bertolini L; Diamond L
    Int J Cancer; 1976 Oct; 18(4):521-9. PubMed ID: 61946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophoretic mobility of mouse T-cell hybrids.
    Bubeník J; Perlmann P; Jónsdóttir I; Kypĕnová H; Bubeníková D; Símová J
    Br J Cancer; 1981 Nov; 44(5):692-9. PubMed ID: 6976180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific reversal of cytolytic T cell-target cell functional binding is induced by free target cells.
    Balk SP; Mescher MF
    J Immunol; 1981 Jul; 127(1):51-7. PubMed ID: 6787131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymus-derived inhibitor of lymphocyte proliferation. II. Tissue specificity in vitro and in vivo.
    Rijke EO; Lempers HC; Ballieux RE
    Cell Tissue Kinet; 1981 Jan; 14(1):31-8. PubMed ID: 6451295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell-stimulating activity of lymphoid cell membrane fractions.
    Sekita K; Straub C; Hoessli D; Zubler RH
    Eur J Immunol; 1988 Sep; 18(9):1405-10. PubMed ID: 3049119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of lymphocyte-mediated cytolysis. V. The use of cytochalasins A and B to dissociate glucose transport from the lytic event.
    Bubbers JE; Henney CS
    J Immunol; 1975 Jul; 115(1):145-49. PubMed ID: 807622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of a T-cell-dependent immune response in vitro by thymoma cell immunoglobulin.
    Stocker JW; Marchalonis JJ; Harris AW
    J Exp Med; 1974 Mar; 139(3):785-90. PubMed ID: 4591179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.